Tetradecylthioacetic acid increases fat metabolism and improves cardiac function in experimental heart failure

Lipids

Volumn 48, Issue 2, 2013, Pages 139-154

  Øie, Erik ^a,d   Berge, Rolf K ^b,c   Ueland, Thor ^a,e   Dahl, Christen P ^a,d   Edvardsen, Thor ^a,d,e   Beitnes, Jan Otto ^a   Bohov, Pavol ^c   Aukrust, Pål ^a,d,e   Yndestad, Arne ^a,d,e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Cardiac function; Fatty acids; Heart failure; Metabolism; Myocardial infarction; Polyunsaturated fatty acids

Indexed keywords

2,4 DIENOYL COENZYME A REDUCTASE (NADPH); 2,4 DIENOYL COENZYME A REDUCTASE (NADPH) 1; ACYL COENZYME A OXIDASE; ACYL COENZYME A OXIDASE 1; ALANINE AMINOTRANSFERASE; ARACHIDONIC ACID; ASPARTATE AMINOTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE I; CD36 ANTIGEN; CHOLESTEROL; DOCOSAHEXAENOIC ACID; FATTY ACID DERIVATIVE; FATTY ACID TRANSPORTER; FATTY ACID TRANSPORTER 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TETRADECYLTHIOACETIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GENE EXPRESSION; GLUCOSE METABOLISM; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; LIPID COMPOSITION; LIPID DIET; LIPID METABOLISM; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN EXPRESSION; RAT; STRUCTURE ANALYSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ANIMALS; ANTIOXIDANTS; FATS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HEART; HEART FAILURE; HEMODYNAMICS; LIPID METABOLISM; LIPIDS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; OXIDATION-REDUCTION; RATS; RATS, WISTAR; SULFIDES;

ANIMALIA; RATTUS;

EID: 84878344682     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-012-3749-z     Document Type: Article

References (24)

1. Berge K, Tronstad KJ, Flindt EN, Rasmussen TH, Madsen L, Kristiansen K, Berge RK (2001) Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways. Carcinogenesis 22:1747-1755. doi: 10.1093/carcin/22.11.1747
2. Berge RK, Skorve J, Tronstad KJ, Berge K, Gudbrandsen OA, Grav H (2002) Metabolic effects of thia fatty acids. Curr Opin Lipidol 13:295-304
3. Berge RK, Tronstad KJ, Berge K, Rost TH, Wergedahl H, Gudbrandsen OA, Skorve J (2005) The metabolic syndrome and the hepatic fatty acid drainage hypothesis. Biochimie 87:15-20. doi: 10.1016/j.biochi.2004.11.011
4. Bordoni A, Astolfi A, Morandi L, Pession A, Danesi F, Di Nunzio M, Franzoni M, Biagi P, Pession A (2007) N-3 PUFAs modulate global gene expression profile in cultured rat cardiomyocytes. Implications in cardiac hypertrophy and heart failure. FEBS Lett 581:923-929. doi: 10.1016/j.febslet.2007.01.070
5. Bremer J (1981) The effect of fasting on the activity of liver carnitine palmitoyltransferase and its inhibition by malonyl-CoA. Biochim Biophys Acta 665:628-631
6. Ghio S, Scelsi L, Latini R, Masson S, Eleuteri E, Palvarini M, Vriz O, Pasotti M, Gorini M, Marchioli R, Maggioni A, Tavazzi L (2010) Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Eur J Heart Fail 12:1345-1353. doi: 10.1093/eurjhf/hfq172
7. Gross GJ, Falck JR, Gross ER, Isbell M, Moore J, Nithipatikom K (2005) Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. Cardiovasc Res 68:18-25. doi: 10.1016/j.cardiores.2005.06.007
8. Hafstad AD, Khalid AM, Hagve M, Lund T, Larsen TS, Severson DL, Clarke K, Berge RK, Aasum E (2009) Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss. Cardiovasc Res 83:519-526. doi: 10.1093/cvr/cvp132
9. Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007-2018. doi: 10.1056/NEJMra021498
10. Kolwicz SC Jr, Tian R (2009) Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization? Trends Cardiovasc Med 19:201-207. doi: 10.1016/j.tcm.2009.12.005
11. Koonen DP, Glatz JF, Bonen A, Luiken JJ (2005) Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim Biophys Acta 1736:163-180. doi: 10.1016/j.bbalip.2005.08.018
12. Marchioli R, Silletta MG, Levantesi G, Pioggiarella R (2009) Omega-3 fatty acids and heart failure. Curr Atheroscler Rep 11:440-447. doi: 10.1007/s11883-009-0066-y
13. Pettersen RJ, Muna ZA, Kuiper KK, Svendsen E, Muller F, Aukrust P, Berge RK, Nordrehaug JE (2001) Sustained retention of tetradecylthioacetic acid after local delivery reduces angioplasty-induced coronary stenosis in the minipig. Cardiovasc Res 52:306-313. doi: 10.1016/S0008-6363(01)00404-7
14. Roche TE, Hiromasa Y (2007) Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Cell Mol Life Sci 64:830-849. doi: 10.1007/s00018-007-6380-z
15. Small GM, Burdett K, Connock MJ (1985) A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. Biochem J 227:205-210. doi: biochemj00306-0201
16. Stanley WC, Recchia FA, Lopaschuk GD (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85:1093-1129. doi: 10.1152/physrev.00006.2004
17. Strand E, Bjorndal B, Nygard O, Burri L, Berge C, Bohov P, Christensen BJ, Berge K, Wergedahl H, Viste A, Berge RK (2012) Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat. Lipids in health and disease 11:82. doi: 10.1186/1476-511X-11-82
18. Swynghedauw B (1999) Molecular mechanisms of myocardial remodeling. Physiol Rev 79:215-262
19. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372:1223-1230. doi: 10.1016/S0140-6736(08)61239-8
20. van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ (2009) Metabolic remodelling of the failing heart: beneficial or detrimental? Cardiovasc Res 81:420-428. doi: 10.1093/cvr/cvn282
21. Wergedahl H, Liaset B, Gudbrandsen OA, Lied E, Espe M, Muna Z, Mork S, Berge RK (2004) Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. J Nutr 134:1320-1327
22. Witte KK, Clark AL (2004) Fish oils-adjuvant therapy in chronic heart failure? Eur J Cardiovasc Prev Rehabil 11:267-274. doi: 10.1097/01.hjr. 0000136728.27524.f5
23. Øie E, Vinge LE, Tønnessen T, Grøgaard HK, Kjekshus H, Christensen G, Smiseth OA, Attramadal H (1997) Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats. Am J Physiol Heart Circ Physiol 273:H1727-H1736
24. Aarsland A, Aarsaether N, Bremer J, Berge RK (1989) Alkylthioacetic acids (3-thia fatty acids) as non-beta-oxidizable fatty acid analogues: a new group of hypolipidemic drugs. III. Dissociation of cholesterol- and triglyceride-lowering effects and the induction of peroxisomal beta-oxidation. J Lipid Res 30:1711-1718